Prof. Albert Rizvanov graduated from Kazan State
University, Russia (biology, microbiology) in 1996. After completing his Ph.D.
(2003) in cellular and molecular biology at the University of Nevada, Reno,
USA, he undertook his Dr.Sci. (2011) in biochemistry (Habilitation) at Kazan
Federal University (KFU), Russia. Currently, he is a Professor at the
Department of Genetics and Head of the Center of Excellence "Personalized
Medicine", Institute of Fundamental Medicine and Biology, KFU. He is the
head of the OpenLab Gene and Cell Technologies Laboratory and Director of the
Department of Exploratory Researches of Pharmaceutical Research and Education
Center. He is the principal investigator of numerous projects, with more than 60 grants supported by
NATO, the British Council, the Russian Science Foundation, the Russian Foundation for Basic
Research, and other Russian government federal programs and industry contracts.
His fields of expertise include regenerative medicine, precision medicine, gene
and cell therapy, molecular neurobiology, molecular virology, cancer
diagnostics, and therapy. From 2019 to 2021, he was an honorary professor at the
Faculty of Medicine and Health Sciences, University of Nottingham, UK. Prof.
Albert Rizvanov is a corresponding member and Academician-Secretary of the
Division of Medical and Biological Sciences of the Tatarstan Academy of
Sciences.
